## Verdict: REVISE — 6.30/10

The proposal has a strong scientific spine: it directly addresses the repStat failure, preserves all eight independent branches, separates learned artifacts, and treats negative branch outcomes as informative. It is not yet implementation-ready because several central “objects” remain verbal rather than mathematical, some falsifications do not isolate their claimed mechanism, and Papers 5–8 contain unresolved identifiability or interface problems.

| Dimension | Score | Weight | Weighted |
|---|---:|---:|---:|
| Problem Fidelity | 8.0 | 15% | 1.200 |
| Method Specificity | 5.5 | 25% | 1.375 |
| Contribution Quality | 6.5 | 25% | 1.625 |
| Frontier Leverage | 7.0 | 15% | 1.050 |
| Feasibility | 5.5 | 10% | 0.550 |
| Validation Focus | 5.5 | 5% | 0.275 |
| Venue Readiness | 4.5 | 5% | 0.225 |
| **OVERALL** |  |  | **6.300/10** |

### Principal assessment

Problem fidelity is the strongest aspect. The proposal preserves the original concern—whether local empirical electrical processes contain useful information beyond architecture capacity or conventional summaries—and explicitly rejects named-wave semantics and non-rejection-as-equivalence ([proposal](/home/mithunmanivannan/projects/benchmarking_loss_functions_ecg_reconstruction/experiments/ptbxl_distributional_repecg/refine-logs/round-0-initial-proposal.md:5)). The fold firewall, branch-local fitting, and locked test contract are also sound ([reconciliation](/home/mithunmanivannan/projects/benchmarking_loss_functions_ecg_reconstruction/experiments/ptbxl_distributional_repecg/docs/SPEC_RECONCILIATION.md:29)).

The central weakness is the gap between architectural specificity and mathematical specificity. The document gives many dimensions and hyperparameters, but not a complete definition of the empirical cell distribution, Nyström coordinates, recurrence affinity, conditional estimator, Koopman estimator, continuous-operator observation model, or equivalence-token assignment rule.

Also, “clinically useful” is not operationalized. With the present task, the defensible claim is “diagnostically useful on PTB-XL,” unless a clinical use criterion is explicitly defined.

## Required repairs for scores below 7

| Dimension | Specific weakness | Concrete method-level fix | Priority |
|---|---|---|---|
| Method Specificity | The shared primitive is underspecified. It is unclear what constitutes an atom in a cell distribution, which axes are pooled, how whitening interacts with physical-mV preservation, and how Nyström features are regularized. Several downstream objects are likewise only named. | Freeze equations and tensor contracts for \(z_{rbc\tau}\), \(\hat P_{rc}\), the kernel, landmark selection, Nyström normalization/ridge, missing-cell behavior, affinity construction, and every learned transform’s fit population. Give each branch explicit input/output shapes. | **P0—blocking implementation** |
| Contribution Quality | The common measurement-layer contribution is focused, but the “program succeeds if any branch wins” formulation risks portfolio cherry-picking. Paper 7 additionally changes several modules at once. | Give every branch exactly one primary claim, one primary comparator, one mechanism endpoint, and one failure interpretation. Treat the eight outcomes independently; if an “at least one succeeds” statistical claim remains, correct across the eight locked primary tests. Keep all branches runnable. | **P0—blocking claims** |
| Feasibility | Two-cycle eligibility may provide too few observations for split-half stability or a 32-anchor patient operator. Paper 8’s adaptive confidence-bound clustering may be costly and statistically unstable. Existing GPU estimates omit preprocessing, exact-pair audits, storage, and bootstrap cost. | Before final runs, freeze per-record sufficiency rules based on actual atom/transition counts. Benchmark runtime, memory, cache size, and bootstrap cost on the development folds. Use explicit regularization/shrinkage for Papers 5–6 and emit `ineligible` rather than silently producing degenerate objects. | **P0—blocking execution** |
| Validation Focus | “Material,” “substantial,” “unacceptable,” “nearly,” and “indistinguishable” are not executable gates. Several destructive transformations create general corruption rather than isolating the proposed mechanism. Claims 3–8 lack the specificity given to Claims 1–2 ([proposal](/home/mithunmanivannan/projects/benchmarking_loss_functions_ecg_reconstruction/experiments/ptbxl_distributional_repecg/refine-logs/round-0-initial-proposal.md:175)). | Predeclare task-effect ROPEs, stability floors, mechanism-effect direction/minimum size, uncertainty calculation, and tie rules. Pair each destroyer with a sham perturbation preserving the matched control’s sufficient statistics. Fold 10 may narrow a claim but must never trigger refitting or a new analysis choice. | **P0—blocking freeze** |
| Venue Readiness | This is a coherent research program, not yet a reviewable method submission. No branch currently has a complete estimator-to-claim contract. | Produce a frozen mathematical specification, eight-row claim/control/falsification matrix, leakage manifest, eligibility reconciliation, and measured execution budget before interpreting pilot results. | **P1** |

## Branch-level method audit

All eight branches should remain independently runnable, but these interfaces must be resolved:

1. **Distributional recurrence:** Define the MMD-to-affinity map, bandwidth fitting, zero-degree handling, vectorization, and exactly how cyclic-neighbor suppression is applied. Phase permutation must be compared with a sham reindexing so it tests phase structure rather than generic matrix disorder.

2. **Kernel-mean ECG:** Comparing nonlinear KME with moments is a control, not a mechanism destroyer. Add a moment-preserving surrogate—such as a train-defined Gaussian surrogate preserving cell mean/covariance—so higher-order information is destroyed while moment controls remain unchanged.

3. **Path signatures:** Specify path channels, base point, lead ordering, log-signature convention, feature dimension, and distributional pooling. The order-destruction control should preserve endpoints and sample marginals.

4. **Local Hankel operators:** Freeze the Hankel matrix construction, rank-selection rule, complex eigenvalue encoding, unstable-mode handling, and descriptor normalization. Temporal scrambling needs a matched surrogate so the result cannot be attributed merely to obvious out-of-distribution corruption.

5. **Recurrent-state Koopman:** Define the temporal unit and estimator. A patient-specific 32-dimensional EDMD/Koopman operator may be underdetermined for short ECGs. Require a transition-count/rank gate and either a preregistered ridge estimator or a shrinkage transition embedding; if the latter is used, call it a transition embedding rather than Koopman.

6. **Conditional residual repStat:** Define the rank-3 macrostate estimator and the conditional-distribution operator. If this is a conditional mean embedding, specify covariance operators, ridge regularization, and recurrence distance. The existing pairing permutation is one of the cleaner proposed falsifications.

7. **Continuous measurement operator:** The acquisition interface is currently ambiguous. If all eight basis leads are available, held-out derived leads are deterministic and reconstruction is nearly trivial. Define observed pairs \((q_j,x_{q_j})\), unavailable target operators, and the diagnosis input. State the expected sign law as an equation. The MLP, CNN, Set Transformer, and reconstruction head currently create a capacity confound ([proposal](/home/mithunmanivannan/projects/benchmarking_loss_functions_ecg_reconstruction/experiments/ptbxl_distributional_repecg/refine-logs/round-0-initial-proposal.md:121)).

8. **Statistical tokens:** Define how the practical margin \(\delta\) is independently calibrated, how adaptive pairwise UCBs handle multiplicity, the patient-clustered bootstrap unit, vocabulary assignment, and “unknown.” “Better token quality” is not a mechanism falsification; compare UCB-equivalence merging with a size-matched merge that destroys the equivalence criterion while retaining vocabulary size and transformer capacity.

The proposed perturbations support causal statements about dependence of the computational pipeline, not biological causality. “Mechanism-use falsification” is the safer claim.

## Simplification Opportunities

- Use one typed shared artifact contract for records, beats, phase cells, kernel coordinates, eligibility, and provenance. Branches may reuse code but must still fit learned objects independently.
- Keep the reconciled Paper 1 direct representation as the sole primary analysis; spectral and 2-D CNN variants remain fully implemented but secondary, as already implied by the conflict record ([reconciliation](/home/mithunmanivannan/projects/benchmarking_loss_functions_ecg_reconstruction/experiments/ptbxl_distributional_repecg/docs/SPEC_RECONCILIATION.md:22)).
- Make Paper 7’s primary model one operator-conditioned set encoder plus diagnosis head. Retain target reconstruction as a preregistered secondary analysis, not a simultaneous source of primary evidence.
- Stage every branch as: object-invariant tests → mechanism smoke test → single-seed development → frozen five-seed final run. This preserves all implementation scope.

## Modernization Opportunities

- For Paper 7, use operator geometry and explicit sign/permutation equivariance instead of adding depth or more heads.
- For Papers 5–6, modern regularized operator estimation is appropriate; additional neural modules are not.
- The small masked transformer is natural for Paper 8. Foundation-model scaling, diffusion models, and generic attention elsewhere would add confounding rather than leverage.

## Drift Warning

**Limited but material drift exists.**

- Paper 7 can drift into generic flexible-lead reconstruction unless the primary question remains whether distribution-valued phase responses improve diagnosis or operator generalization over raw-response controls.
- Paper 8 can drift into tokenizer/transformer benchmarking unless the contribution remains the confidence-bound equivalence rule.
- Papers 4–5 must not be presented as generic DMD or Koopman novelty; the proposal correctly recognizes this, but the final claims must enforce it.

## Remaining action items

1. **P0:** Write the frozen mathematical and tensor-interface specification for the shared measurement layer.
2. **P0:** Complete an eight-row claim–control–destroyer–endpoint–kill-rule table with numeric gates.
3. **P0:** Resolve the Paper 5 estimator, Paper 6 conditioning operator, Paper 7 acquisition interface, and Paper 8 equivalence calibration.
4. **P0:** Freeze eligibility, `ineligible` handling, denominators, patient aggregation, seed aggregation, and multiplicity policy.
5. **P0:** Ensure fold-10 observations can only constrain reporting; run the already-specified fixed-window sensitivity unconditionally or decide its activation before opening fold 10.
6. **P1:** Measure CPU, storage, GPU, and bootstrap costs through the staged smoke runs; replace provisional estimates with observed throughput.
7. **P1:** Freeze separate paper claims so failed branches remain valid negative findings and successful branches cannot retroactively redefine the program claim.
8. **P2:** Mark every non-primary architecture and sensitivity explicitly in the freeze manifest.

**Final verdict: REVISE.** The anchored idea is worth pursuing and does not require removing any branch. It needs a mathematical-interface freeze and executable falsification protocol before implementation at scale.

Review basis: direct audit of the two supplied files. The optional external-review backend was unavailable in this session, so this is not a cross-model consensus review.
